Prisons test injectable opioid addiction treatment

File HB4708 ("Prisons test injectable opioid addiction treatment") is before the Illinois Legislature and has not been decided. Latest step (May 22, 2026): Rule 3-9(a) / Re-referred to Assignments.

Illinois file HB4708, before the Illinois Legislature. Still to be decided as of 2026-05-22.

What it does

Incarcerated people gain access to proven addiction medication If you are incarcerated in Illinois with opioid use disorder, you may receive long-acting injectable medications (like buprenorphine or naltrexone formulations) starting January 2027, with a planned referral to community harm reduction services upon release.

The bigger picture

Reduces overdose deaths during and after incarceration By treating opioid addiction before release and linking people to community providers, the program aims to lower overdose mortality during the vulnerable reentry period, which currently claims thousands of formerly incarcerated individuals annually.

Official summary

Amends the Unified Code of Corrections. Provides that the Department of Corrections shall create and implement, on January 1, 2027, a pilot program to establish the effectiveness of long-acting injectable medications for opioid use disorders for persons committed to its custody who suffer from opioid use disorders. Provides that the pilot program shall require long-acting injectable medications for opioid use disorders to be used in at least one Department of Corrections facility. Provides that the Director may expand the pilot program to include an additional facility or facilities as he or she deems appropriate. Provides that a minimum of 4,000 administrations of long-acting injectable medications for opioid use disorders shall be included in the pilot program. Provides that the Department shall develop a plan to facilitate access to continued treatment for opioid use disorders in the community following the release of a person participating in the pilot program, including, but not limited to, a referral to a harm reduction provider. Provides that the Department must report to the General Assembly on the effectiveness of the program by January 1, 2028. Effective immediately.

How they voted

Yes (75)

No (32)

Did not vote / other (10)

Read the official record for HB4708

See everything up for a vote · This week in Illinois · See what we have filed with the clerk